Advanced search
Publication Cover
Epigenetics Volume 16, 2021 - Issue 1
Submit an article Journal homepage
3,496
Views
10
CrossRef citations to date
0
Altmetric
Research Paper

Hypoxia and hypoxia mimetics differentially modulate histone post-translational modifications

Kuo-Feng Hsua Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UK;b Tri-Service General Hospital, National Defense Medical Center, Taipei, TaiwanORCID Iconhttps://orcid.org/0000-0001-9556-9221View further author information
ORCID Icon,
Sarah E. Wilkinsa Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UKORCID Iconhttps://orcid.org/0000-0003-1347-3328View further author information
ORCID Icon,
Richard J. Hopkinsona Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UK;c Leicester Institute of Structural and Chemical Biology and School of Chemistry, University of Leicester, Leicester, UKORCID Iconhttps://orcid.org/0000-0001-7610-8163View further author information
ORCID Icon,
Rok Sekirnika Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UKView further author information
,
Emily Flashmana Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UKORCID Iconhttps://orcid.org/0000-0002-4169-4278View further author information
ORCID Icon,
Akane Kawamuraa Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UK;d Radcliffe Department of Medicine, Division of Cardiovascular Medicine, BHF Centre of Research Excellence, Wellcome Trust Centre for Human Genetics, Oxford, UK;e Chemistry - School of Natural and Environmental Sciences, Newcastle University, UKORCID Iconhttps://orcid.org/0000-0003-1169-5082View further author information
ORCID Icon,
James S.O. McCullagha Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UKORCID Iconhttps://orcid.org/0000-0003-4733-1205View further author information
ORCID Icon,
Louise J. Walporta Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UK;f Protein-Protein Interaction Laboratory, The Francis Crick Institute, London, UK;g Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3795-8365View further author information
ORCID Icon &
Christopher J. Schofielda Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0290-6565View further author information
ORCID Icon show all
Pages 14-27 | Received 06 Mar 2020, Accepted 22 May 2020, Published online: 01 Jul 2020

References

  • Kaelin WG Jr., Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell. 2008;30:393–402.
  • Semenza GL. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med. 2001;7:345–350.
  • Wang GL, Semenza GL. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci. 1993;90:4304 LP– 4308.
  • Jaakkola P, Mole DR, Tian Y-M, et al. Targeting of HIF-α to the von hippel-lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001;292:468–472.
  • Epstein ACR, Gleadle JM, McNeill LA, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 2001;107:43–54.
  • Bruick RK, McKnight SL. A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF. Science. 2001;294:1337–1340.
  • Batie M, Del Peso L, Rocha S. Hypoxia and chromatin: A focus on transcriptional repression mechanisms. Biomedicines. 2018;6:1–19.
  • Perez-Perri JI, Acevedo JM, Wappner P. Epigenetics: new questions on the response to hypoxia. Int J Mol Sci. 2011;12:4705–4721.
  • Choudhry H, Harris AL. Advances in hypoxia-inducible factor biology. Cell Metab. 2017;27:281–298.
  • Johnson AB, Denko N, Barton MC. Hypoxia induces a novel signature of chromatin modifications and global repression of transcription. Mutat Res. 2008;640:174–179.
  • Pollard PJ, Loenarz C, Mole D, et al. Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1a. Biochem J. 2008;416:387–394.
  • Hancock RL, Dunne K, Walport LJ, et al. Epigenetic regulation by histone demethylases in hypoxia. Epigenomics. 2015;7:791–811.
  • Tausendschön M, Dehne N, Brüne B. Hypoxia causes epigenetic gene regulation in macrophages by attenuating Jumonji histone demethylase activity. Cytokine. 2011;53:256–262.
  • Prickaerts P, Adriaens ME, Beucken TVD, et al. Hypoxia increases genome-wide bivalent epigenetic marking by specific gain of H3K27me3. Epigenet Chromatin. 2016;9:1–19.
  • Hancock RL, Masson N, Dunne K, et al. The activity of JmjC histone lysine demethylase KDM4A is highly sensitive to oxygen concentrations. ACS Chem Biol. 2017;12:1011–1019.
  • Batie M, Frost J, Frost M, et al. Hypoxia induces rapid changes to histone methylation and reprograms chromatin. Science. 2019;363:1222–1226.
  • Klose RJ, Kallin EM, Zhang Y. JmjC-domain-containing proteins and histone demethylation. Nat Rev Genet. 2006;7:715–727.
  • Walport LJ, Hopkinson RJ, Schofield CJ. Mechanisms of human histone and nucleic acid demethylases. Curr Opin Chem Biol. 2012;16:525–534.
  • Knowles HJ, Raval RR, Harris AL, et al. Effect of Ascorbate on the Activity of Hypoxia-inducible Factor in Cancer Cells. Cancer Res. 2003;63:1764 LP– 1768.
  • Cho EA, Song HK, Lee S-H, et al. Differential in vitro and cellular effects of iron chelators for hypoxia inducible factor hydroxylases. J Cell Biochem. 2012;114:864–873.
  • Tian Y-M, Yeoh KK, Lee MK, et al. Differential sensitivity of hypoxia inducible factor hydroxylation sites to hypoxia and hydroxylase inhibitors. J Biol Chem. 2011;286:13041–13051.
  • Nurchi VM, Crisponi G, Lachowicz JI, et al. Chemical features of in use and in progress chelators for iron overload. J Trace Elem Med Biol. 2016;38:10–18.
  • Moukalled NM, Bou-Fakhredin R, Taher AT. Deferasirox: over a decade of experience in thalassemia. Mediterr J Hematol Infect Dis. 2018;10:1–13.
  • Rose NR, McDonough MA, King ONF, et al. Inhibition of 2-oxoglutarate dependent oxygenases. Chem Soc Rev. 2011;40:4364–4397.
  • Bush JT, Chan MC, Mohammed S, et al. Quantitative MS-based proteomics comparing the MCF-7 cellular response to hypoxia and a 2-oxoglutarate analogue. Chembiochem. 2020;21:1647–1655.
  • Maxwell P, Salnikow K. HIF-1: an oxygen and metal responsive transcription factor. Cancer Biol Ther. 2004;3:29–35.
  • Chowdhury R, Candela-Lena JI, Chan MC, et al. Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases. ACS Chem Biol. 2013;8:1488–1496.
  • Becker K, Saad M. A new approach to the management of anemia in CKD patients: a review on roxadustat. Adv Ther. 2017;34:848–853.
  • Pogribny IP, Tryndyak VP, Pogribna M, et al. Modulation of intracellular iron metabolism by iron chelation affects chromatin remodeling proteins and corresponding epigenetic modifications in breast cancer cells and increases their sensitivity to chemotherapeutic agents. Int J Oncol. 2013;42:1822–1832.
  • Roatsch M, Hoffmann I, Abboud MI, et al. The clinically used iron chelator deferasirox is an inhibitor of epigenetic JumonjiC domain-containing histone demethylases. ACS Chem Biol. 2019;14:1737–1750.
  • Sidoli S, Garcia BA. Properly reading the histone code by MS-based proteomics. Proteomics. 2015;15:2901–2902.
  • Sidoli S, Cheng L, Jensen ON. Proteomics in chromatin biology and epigenetics: elucidation of post-translational modifications of histone proteins by mass spectrometry. J Proteomics. 2012;75:3419–3433.
  • Eberl HC, Mann M, Vermeulen M. Quantitative proteomics for epigenetics. Chembiochem. 2011;12:224–234.
  • Thomas CE, Kelleher NL, Mizzen CA. Mass spectrometric characterization of human histone H3: a bird’s eye view. J Proteome Res. 2006;5: 240–247.
  • Moradian A, Kalli A, Sweredoski MJ, et al. The top-down, middle-down, and bottom-up mass spectrometry approaches for characterization of histone variants and their post-translational modifications. Proteomics. 2014;14:489–497.
  • Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003;422:198–207.
  • Sidoli S, Lopes M, Lund PJ, et al. A mass spectrometry-based assay using metabolic labeling to rapidly monitor chromatin accessibility of modified histone proteins. Sci Rep. 2019;9:1–15.
  • Naldi M, Andrisano V, Fiori J, et al. Histone proteins determined in a human colon cancer by high-performance liquid chromatography and mass spectrometry. J Chromatogr A. 2006;1129:73–81.
  • Su X, Jacob NK, Amunugama R, et al. Liquid chromatography mass spectrometry profiling of histones. J Chromatogr B Anal Technol Biomed Life Sci. 2007;850:440–454.
  • Contrepois K, Ezan E, Mann C, et al. Ultra-high performance liquid chromatography-mass spectrometry for the fast profiling of histone post-translational modifications. J Proteome Res. 2010;9:5501–5509.
  • Drogaris P, Villeneuve V, Pomiès C, et al. Histone deacetylase inhibitors globally enhance h3/h4 tail acetylation without affecting h3 lysine 56 acetylation. Sci Rep. 2012;2:220.
  • Li M, Jiang L, Kelleher NL. Global histone profiling by LC-FTMS after inhibition and knockdown of deacetylases in human cells. J Chromatogr B Anal Technol Biomed Life Sci. 2009;877:3885–3892.
  • Naldi M, Calonghi N, Masotti L, et al. Histone post-translational modifications by HPLC-ESI-MS after HT29 cell treatment with histone deacetylase inhibitors. Proteomics. 2009;9:5437–5445.
  • Shechter D, Dormann HL, Allis CD, et al. Extraction, purification and analysis of histones. Nat Protoc. 2007;2:1445–1457.
  • Khare SP, Habib F, Sharma R, et al. HIstome - A relational knowledgebase of human histone proteins and histone modifying enzymes. Nucleic Acids Res. 2012;40:337–342.
  • Strober W. Trypan Blue Exclusion Test of Cell Viability. Curr Protoc Immunol. 2001;21:A.3B.1-A.3B.2.
  • Marks PA, Breslow R. Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug. Nat Biotechnol. 2007;25:84–90.
  • Hole K, Van Damme P, Dalva M, et al. The human N-Alpha-acetyltransferase 40 (hNaa40p/hNatD) is conserved from yeast and N-terminally acetylates histones H2A and H4. PLoS One. 2011;6:1–11.
  • Rogakou EP, Pilch DR, Orr AH, et al. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem. 1998;273:5858–5868.
  • Rose NR, Ng SS, Mecinoić J, et al. Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases. J Med Chem. 2008;51:7053–7056.
  • Pesavento JJ, Mizzen CA, Kelleher NL. Quantitative analysis of modified proteins and their positional isomers by tandem mass spectrometry: human histone H4. Anal Chem. 2006;78:4271–4280.
  • Noberini R, Sigismondo G, Bonaldi T. The contribution of mass spectrometry-based proteomics to understanding epigenetics. Epigenomics. 2016;8:429–445.
  • Molden RC, Garcia BA. Middle-down and top-down mass spectrometric analysis of co-occurring histone modifications. Curr Protoc Protein Sci. 2014;77:23.7.1–23.7.28.
  • You J, Wang L, Saji M, et al. High-sensitivity TFA-free LC-MS for profiling histones. Proteomics. 2011;11:3326–3334.
  • Galasinski SC, Resing KA, Ahn NG. Protein mass analysis of histones. Methods. 2003;31:3–11.
  • Xia X, Lemieux ME, Li W, et al. Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis. Proc Natl Acad Sci. 2009;106:4260–4265.
  • Chen H, Yan Y, Davidson TL, et al. Hypoxic stress induces dimethylated histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells. Cancer Res. 2006;66:9009–9016.
  • Chakraborty AA, Laukka T, Myllykoski M, et al. Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate. Science. 2019;363:1217–1222.
  • Yang J, Ledaki I, Turley H, et al. Role of hypoxia-inducible factors in epigenetic regulation via histone demethylases. Ann N Y Acad Sci. 2009;1177:185–197.
  • Wellmann S, Bettkober M, Zelmer A, et al. Hypoxia upregulates the histone demethylase JMJD1A via HIF-1. Biochem Biophys Res Commun. 2008;372:892–897.
  • Ferrige AG, Seddon MJ, Jarvis S, et al. Maximum entropy deconvolution in electrospray mass spectrometry. Rapid Commun Mass Spectrom. 1991;5:374–377.
  • Ferrige AG, Seddon MJ, Green BN, et al. Disentangling electrospray spectra with maximum entropy. Rapid Commun Mass Spectrom. 1992;6:707–711.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.